欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/0104/001
药品名称Naropin 2 mg/ml, injectievloeistof voor perineurale en epidurale toediening
活性成分
    • ropivacaine 2.0 mg/ml
剂型Solution for injection
上市许可持有人Aspen Pharma Trading Limited 3016 Lake Drive, Citywest Business Campus Dublin 24 Ireland
参考成员国 - 产品名称Netherlands (NL)
Naropin 2 mg/ml
互认成员国 - 产品名称
    • Belgium (BE)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Naropin 2 mg/ml - Injektionslösung/Infusionslösung
    • France (FR)
    • Italy (IT)
    • Germany (DE)
许可日期1996/04/22
最近更新日期2024/02/07
药物ATC编码
    • A ALIMENTARY TRACT AND METABOLISM
    • N01BB09 ropivacaine
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase